BriaCell Therapeutics Corp. (BCT.TO)
5.31
-0.30
(-5.35%)
CAD |
TSX |
Oct 13, 16:00
BriaCell Therapeutics Net Income (Quarterly) : -9.920M for April 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -9.920M |
| January 31, 2026 | -10.12M |
| October 31, 2025 | -11.49M |
| July 31, 2025 | -11.22M |
| April 30, 2025 | -8.850M |
| January 31, 2025 | -9.001M |
| October 31, 2024 | -7.962M |
| July 31, 2024 | -1.710M |
| April 30, 2024 | 2.297M |
| January 31, 2024 | -15.32M |
| October 31, 2023 | 8.090M |
| July 31, 2023 | -3.228M |
| April 30, 2023 | -6.632M |
| January 31, 2023 | -16.02M |
| October 31, 2022 | -1.472M |
| April 30, 2022 | -12.69M |
| January 31, 2022 | 14.14M |
| October 31, 2021 | -34.60M |
| April 30, 2021 | 3.713M |
| January 31, 2021 | -0.2898M |
| October 31, 2020 | -0.4866M |
| July 31, 2020 | -0.6956M |
| April 30, 2020 | -0.7006M |
| January 31, 2020 | -1.883M |
| October 31, 2019 | -1.647M |
| Date | Value |
|---|---|
| July 31, 2019 | -1.695M |
| April 30, 2019 | -1.523M |
| January 31, 2019 | -1.584M |
| October 31, 2018 | -1.048M |
| July 31, 2018 | -2.144M |
| April 30, 2018 | -1.656M |
| January 31, 2018 | -0.9765M |
| October 31, 2017 | -0.641M |
| July 31, 2017 | -1.189M |
| April 30, 2017 | -1.175M |
| January 31, 2017 | -0.4145M |
| October 31, 2016 | -0.4392M |
| July 31, 2016 | -0.3867M |
| April 30, 2016 | -0.4277M |
| January 31, 2016 | -0.9975M |
| October 31, 2015 | -0.403M |
| July 31, 2015 | -0.3719M |
| April 30, 2015 | -0.4639M |
| January 31, 2015 | -2.592M |
| October 31, 2014 | -0.1313M |
| July 31, 2014 | -8.049M |
| April 30, 2014 | -0.5897M |
| January 31, 2014 | -0.0888M |
| October 31, 2013 | -0.1591M |
| July 31, 2013 | -0.1042M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.8336M |
| Quest PharmaTech, Inc. | 3.401M |
| Vaxil Bio Ltd. | -0.064M |
| Waverley Pharma, Inc. | -0.1437M |
| Goldcoast Resource Corp. | -0.0999M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 9.820M |
| EPS Diluted (Quarterly) | -1.354 |
| Enterprise Value | 6.578M |
| Earnings Yield | -317.7% |
| Normalized Earnings Yield | -324.24 |